Thanks attila. I believe you're right that the Oppenheimer analyst didn't include pancreatic cancer in his $15 price target. I totally forgot about that. Would be nice to see him raise the price target tomorrow morning based on adding it in....
It's possible we get new commentary from analysts, my guess is Monday morning. My guess is likely after the conference call in the morning with Marker.